2 unchanged sentences
Exhibit Number Description
−Removed: 3.1 Amended and Restated Certificate of Incorporation of Senti Biosciences, Inc.
−Removed: 3.2 Amended and Restated Bylaws of Senti Biosciences, Inc.
−Removed: 4.1 Specimen Common Stock Certificate .
−Removed: 10.1* Non-Employee Director Compensation Policy .
−Removed: 10.2* Consulting Agreement between Senti Biosciences, Inc.
−Removed: and David Epstein.
−Removed: 10.3* Severance and Change in Control Agreement between the Company and Deborah Knobelman.
−Removed: 10.4* Severance and Change in Control Agreement between the Company and Philip Lee.
−Removed: 10.5* Severance and Change in Control Agreement between the Company and Tim Lu.
−Removed: 10.6* Senti Biosciences, Inc.
−Removed: 2022 Inducement Plan and form of award agreements thereunder.
+Added: 10.1*# Employee Offer Letter by and between Kanya Rajangam and Senti Biosciences, Inc., dated May 10, 2022.
+Added: 10.2† Side Letter between BlueRock Therapeutics, LP and Senti Biosciences, Inc., dated February 3, 2023.
31.1* Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
16 unchanged sentences
Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.
−Removed: (1) Previously filed as an exhibit to our Current Report on Form 8-K filed on June 15, 2022 and incorporated herein by reference.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 10th day of November, 2022.
−Removed: November 10, 2022
+Added: # Indicates a management contract or a compensatory plan, contract or arrangement.
+Added: † Portions of this exhibit (indicated by asterisks) have been omitted because the registrant has determined that the information is both not material and is of the type that the registrant treats as private or confidential.
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 9th day of May, 2023.
SENTI BIOSCIENCES, INC.
4 unchanged sentences
Deborah Knobelman, Ph.D.
−Removed: Chief Financial Officer
+Added: Chief Financial Officer and Head of Corporate Development
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.